Everything You Need To Know About Vaccines and COVID-19
Dr. Peter Khoury, president and CEO of UF startup and UF Innovate | Sid Martin Biotech graduate Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), talked with James Di Virgilio, Radio Cade's host, about vaccinations and COVID-19.
Oragenics Chases Vaccine for Niche Markets
UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, seeks to be a major player in the Super Bowl of the pharmaceutical industry: a COVID-19 vaccine.
Biotech Firm Raises $20 Million, Sees Progress on COVID-19 Vaccine
UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc. has raised $20 million from the sale of common stock and will use some of the funding to boost its research into a Covid-19 vaccine.
Dr. Cindy Prins Assesses Spaces Across UF Campus for COVID-19 Transmission Risks
In her role as the infection preventionist for the UF Health Screen, Test and Protect Program, Cindy Prins, Ph.D., clinical associate professor of epidemiology and assistant dean for educational affairs for the UF College of Public Health and Health Professions, offers infection control assessments for UF entities who aim to resume activities throughout campus.
Unsure About the COVID-19 Vaccine? UF Health’s Chief Epidemiologist Has Answers
Nicole M. Iovine, M.D., Ph.D., chief epidemiology officer for the University of Florida Health Shands Hospital system, addresses key issues related to overcoming vaccine hesitancy.
Free Tech Support for Low-Income Seniors Navigating Vaccine Registration
Orchard introduced a free assistance to low-income older adults to help them with the vaccine signup process.
SARS-CoV-2 Spike Protein Licensed by Oragenics From the NIH Demonstrates Protective Immunity in Mice
UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, announces that the stabilized pre-fusion spike protein CoV-2 S-2P created by the National Institutes of Health (“NIH”) and licensed by the Company demonstrates protective immunity in immunized mice challenged with mouse-adapted SARS-CoV-2 virus.
UF Health Pilot Program To Deliver COVID-19 Monoclonal Antibody Therapy to Rural Communities
A University of Florida Health pilot program will bring a new COVID-19 monoclonal antibody therapy to rural communities in North Florida.
UF Health Discovers Possible Risk Factor for COVID-19
A UF research team found vitamin D-deficient patients were four times more likely to be COVID-19 positive than those with a sufficient amount of the crucial vitamin, which people can get from sources like sunlight and animal proteins.
Two-Drug Combo Shows Dramatic Results for COVID-19 Patients, UF Health Researchers Find
Combining an anti-inflammatory drug with an antiviral drug reduces recovery time and accelerates improvement for COVID-19 patients, a national study co-authored by UF Health researchers has found.
